Pay in 4 interest-free payments of $6.79 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Determinants of fibrosis progression and regression in NASH
2026 Guideline on the Management of Dyslipidemia Updated: March 13, 2026 This guideline retires and replaces the 2018 AHA/ACC Guideline on the Management of Blood Cholesterol and is retitled the 2026 Guideline on the Management of Dyslipidemia to reflect the evolving understanding of atherosclerotic cardiovascular disease (ASCVD) risk associated with atherogenic lipoproteins beyond low-density lipoprotein cholesterol (LDL-C), including triglyceride-rich remnant particles and lipoprotein(a) [Lp(a)]
What are you hacks for getting your water in
Stimulation of proteoglycan biosynthesis by serum and insulin-like growth factor-I in cultured bovine articular cartilage
US$ 29.63
US$ 25.94
US$ 21.87
US$ 26.85
US$ 24.14
US$ 27.92
US$ 27.76
